JULIA DINH: Open Payments
NPI 1558970467 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 8 payments from 7 companies in 2025. Trend: 2023 $1,045 · 2024 $794 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $235 |
| SANOFI-AVENTIS U.S. LLC | 1 | $150 |
| Dexcom, Inc. | 1 | $145 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Exact Sciences Corporation | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: TZIELD, DEXCOM G7 GSS (161), REXULTI, REZDIFFRA, The Cologuard Plus Collection Kit, JARDIANCE.
Industry payments across CA — which companies pay providers there.
